Do you live with an Implantable Cardioverter-Defibrillator (ICD)?

Share your experience in this survey and help physicians understand your needs to tailor future information and counselling.

As of today, 1 April 2021, foods containing more than 2g/100g of industrially produced trans fatty acids are no longer allowed on the EU market. The removal of these trans fatty acids (TFAs) from the food supply is one of the most straightforward public health interventions in the EU.

To reduce the onset of cardiovascular disease, it is crucial to identify those persons at high risk of developing CVD, and to provide them with appropriate advice and preventive treatment.

On World Heart Day, EHN stresses the urgent need to adress the increasing burden of CVD, especially in this time of Covid-19 crisis.

Here is an overview of EHN's activities in 2019.

Digital technologies can transform cardiovascular diagnosis and patient care

Having reviewed the latest science, the European Heart Network (EHN) has adopted its position on front of pack nutrition labelling.

The European Heart Network (EHN) is delighted to announce that Birgit Beger will take over as Chief Executive Officer of the EHN on 1 August 2020.

The burden of cardiovascular disease (CVD) is greater than that of any other disease and it is the leading cause of death in Europe and in the world.

EHN welcomes the new EU4Health programme which acknowledges that health promotion, disease prevention, treatment and care, are the cornerstone for well-functioning societies and economies.